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Previous studies revealed that chronic (days) vasopressin
treatment stimulates amiloride-sensitive sodium transport in
isolated renal cortical collecting ducts and increases the
abundance of beta- and gamma-subunits of the epithelial
sodium channel (ENaC) in the kidney. The aim of the
present work was to investigate in vivo the cellular basis
of these effects. The long-term effect of V2 vasopressin
agonist (1-deamino-8-D-arginine vasopressin (dDAVP)) on
the abundance and subcellular localization of ENaC
along the rat renal collecting system was determined
by immunohistochemistry and laser confocal
microscopy. Moreover, we studied by real-time reverse
transcriptase-polymerase chain reaction the effect of
vasopressin on proteins implicated in the regulation of
ENaC (Nedd4-2, prostasin, Sgk1). After 5 days of
administration, dDAVP markedly increased the intracellular
pool of the beta- and gamma-ENaC subunits in the principal
cells, with an increasing gradient from connecting tubule to
the outer medullary collecting duct, but did not increase any
subunit at the cell surface. The apical immunostaining of
ENaC increased in response to sodium restriction, as
expected, but dDAVP did not further enhance this apical
labelling. dDAVP increased the gene expression of prostasin
in the cortex but not that of Nedd4-2 and Sgk1. These
findings suggest that the previously reported increase in
sodium transport induced by sustained stimulation of
vasopressin V2 receptor is probably mediated by other
mechanism than an increase in the apical density of ENaC.
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The regulation of renal sodium excretion is central to the
control of the whole-body sodium level and fluid home-
ostasis. In the mammalian kidney, vasopressin and aldoster-
one play key roles in the fine adjustment of the sodium
reabsorption in the distal part of the nephron. The molecular
target of this regulation is the amiloride-sensitive epithelial
sodium channel (ENaC), which is composed of three
homologous subunits: alpha, beta, and gamma.1 This
channel, present in the apical membrane of the segment-
specific cells of the renal collecting system (i.e. the connecting
tubule (CNT), and the collecting duct (CD)), constitutes a
rate-limiting step for sodium reabsorption by these cells.
Although vasopressin was the first hormone shown to
augment amiloride-sensitive sodium reabsorption in frog
skin and toad bladder, the cellular mechanisms by which
vasopressin regulates ENaC are still incompletely understood.
It has been shown that long-term treatment with vasopressin
markedly increases the expression of beta- and gamma-ENaC
subunits in a rat cortical CD (CCD) cell line2 and in the rat
kidney.3,4 This effect was accompanied by significant increase
in sodium transport in the CCD,2,4 suggesting concomitant
changes in functional ENaC membrane proteins. In vitro
experiments have shown that acute addition of vasopressin or
its second messenger cyclic AMP resulted in an increase of
the apical membrane density of the sodium channels.5–9 No
data has been reported about the possible effects of
vasopressin on the trafficking of ENaC to the luminal
membrane of the renal collecting system in vivo. As ENaC
and aquaporin 2 (AQP2) are colocalized in the CNT cells and
in the principal cells of the CD and because chronic elevation
of vasopressin level increased both expression and cell surface
abundance of AQP2,10 it could be expected that similar
phenomenon occurs for ENaC. In addition, vasopressin
could stimulate the activity of ENaC through proteins
regulating the apical abundance or the open probability of
the channel (ubiquitin ligase, serum and glucocorticoid-
inducible kinase Sgk1, channel-activated protease). The
hormonal regulation of these proteins is unknown, except
for Sgk1 that is rapidly induced by aldosterone both in vivo
and in vitro,11 and which is probably involved in the
aldosterone-dependent redistribution of ENaC subunits from
intracellular compartment to the apical membrane.12
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Interestingly, vasopressin acts synergistically with aldo-
sterone to stimulate sodium reabsorption. Both hormones
increase sodium transport, but the acute effect of vasopressin
is higher in CCD from rats pretreated with aldosterone and
in long-term aldosterone-treated A6 epithelium.13–15 Acute in
vitro exposure of rat CCD to vasopressin also stimulates 11-
beta-hydroxysteroid dehydrogenase activity, and it has been
suggested that this mechanism could account for at least
some of the synergism between vasopressin and aldoster-
one.16 Cyclic AMP and Sgk1 were shown to regulate ENaC
through convergent phosphorylation of Nedd4-2 in hetero-
logous expression systems.17 However, no data is available
about the possible long-term coordinated actions of both
aldosterone and vasopressin in vivo. As aldosterone acts
preferentially on alpha-subunit expression, whereas vaso-
pressin affects the expression of both the beta- and gamma-
subunits, it might be expected that chronic high levels of
both hormones would have additional effects in enhancing
the expression and activity of ENaC. Indeed, in heterologous
expression systems, the alpha-subunit alone can form
functional amiloride-sensitive Na channels, but the channel
activity is greatly enhanced by the association of the three
subunits.1,18 In transfected rat thyroid cells, sodium reab-
sorption requires the coexpression of all three subunits.19 The
alpha-subunit seems to play a key role in the assembly and
cell surface targeting of an active channel as indicated by
findings in Xenopus oocytes,20 Xenopus A6 cells,21 and a
transgenic mouse line with targeted inactivation of alpha-
ENaC in CD.22
The aim of the present study was to investigate the
mechanisms of action involved in the long-term effect of
vasopressin on ENaC, in isolation or combined with a high
aldosterone level. The consequences of various levels of
stimulation of the vasopressin V2 receptor were studied in
Sprague–Dawley rats with either a high water intake (HWI)
or a chronic infusion of 1-deamino-8-D-arginine vasopressin
(dDAVP) and in homozygous Brattleboro rats with heredi-
tary hypothalamic diabetes insipidus23 treated with dDAVP.
Dietary sodium intake was modified to induce changes of
plasma aldosterone in a physiological range. The subcellular
localization and distribution of ENaC subunits along the
distal nephron was investigated by immunofluorescence. The
expression of genes encoding for proteins involved in ENaC
regulation was quantified by real-time reverse transcriptase-
polymerase chain reaction and Western blotting.
RESULTS
Functional data
Sprague–Dawley rats. Treatment with vasopressin V2
agonist or HWI induced major changes in the urine-
concentrating activity (Table 1). Urine osmolality was twice
as high in the dDAVP group as in the control group, and
close to plasma osmolality in the HWI group. Plasma
concentration of aldosterone was not altered by the level of
urine-concentrating activity, but was significantly higher in
the rats fed a low salt diet than in those on a normal salt diet.
Daily sodium excretion was markedly decreased with low
sodium diet (Po0.0001) and was not altered by dDAVP
treatment or HWI. This suggests that animals were in steady
state and that compensatory mechanisms (likely pressure
natriuresis) came into play and masked the consequences of
dDAVP on ENaC and sodium reabsorption.2,4,24
Homozygous Brattleboro rats. Rats receiving chronic
dDAVP infusion exhibited a significantly lower water intake
(2972 vs 9179 ml/day, Po0.0001), urine flow rate (671 vs
5876 ml/day, Po0.0001), and higher urine osmolality
(19517175 vs 281725 mosm/kg H2O, Po0.0001) than
untreated rats.
Effect of vasopressin on the localization of ENaC in the
kidneys of rats with standard Na intake
Figure 1 shows immunolabelling of AQP2, and of the alpha-,
beta-, and gamma-ENaC subunits in representative profiles
of CCD from rats on standard sodium diet, with different
levels of V2 receptor stimulation. In the control rats, AQP2
was seen in the cytoplasm and at the apical plasma
membrane of the segment-specific CD cells (i.e. the principal
cells). In these cells, the alpha-ENaC subunit was weak but
Table 1 | Physiological parameters measured in Sprague–Dawley rats on standard or low Na diet, and with dDAVP infusion,
HWI, or no treatment (CONT)
Standard Na diet Low Na diet Two-way ANOVA
HWI CONT dDAVP HWI CONT dDAVP Na diet Treatment
Body weight (g) 24375 25373 25672 223771 226751 234741 Po0.0001 NS
Urine flow rate (ml/day) 32.671.6* 6.671.5 3.170.2 30.571.6* 11.571.7 3.870.3* NS Po0.0001
Urine osmolality (mosm/kg H2O) 298723* 13617202 2348757* 304737* 9067104 2414740* NS Po0.0001
Na excretion (mmol/day) 10247184 8147127 589755 4721 2711 73761 Po0.0001 NS
Plasma osmolality (mosm/kg H2O) 29674 29572 29271 29176 29472 28176 NS NS
Plasma Na (mmol/l) 14572 14372 14371 14372 14371 13573 NS NS
Plasma K (mmol/l) 3.9770.12 3.6770.13 4.4470.18 4.2670.34 4.6070.191 4.7970.341 P=0.0102 NS
Plasma aldosterone (ng/dl) 10.372.8 13.471.8 15.372.1 75071191 74072541 106271711 Po0.0001 NS
ANOVA=analysis of variance; CONT=control; dDAVP=1-deamino-8-D-arginine vasopressin; HWI=high water intake; NS, not significant.
Means7s.e.m. n=5 per group.
Fisher post hoc test.
*Po0.05 or less, dDAVP or HWI vs CONT for the same Na diet.
1Po0.05 or less, low vs standard Na diet for the same treatment.
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detectable at the apical plasma membrane, whereas beta- and
gamma-ENaC subunits exhibited a vesicular staining pattern
throughout the cytoplasm. Intercalated cells, interspersed
between principal CCD cells, were not stained by AQP2 or
ENaC antibodies. The distinct differences between alpha and
beta/gamma ENaC immunostainings is similar to that
observed previously in normal Sprague–Dawley rats.25
dDAVP treatment increased the immunostaining of AQP2
at the apical membrane, and of beta- and gamma-ENaC in
the cytoplasm of the principal CCD cells, but did not
influence the immunostaining for alpha-ENaC. HWI resulted
in a distinct fall of the immunostaining for AQP2, but did
not significantly modify the immunostaining for any of the
three ENaC subunits compared to that in control rats.
Qualitatively similar changes to those seen in the
Sprague–Dawley rats were obtained in the Brattleboro rats,
a rat strain with no endogenous vasopressin production and,
thus, highly sensitive to exogenous vasopressin. In these rats,
chronic V2 agonist infusion induced a marked increase in the
cytoplasmic immunostaining for the beta-ENaC subunit
(Figure 2) and, to a lesser extent, for the gamma-subunit. The
immunochemical abundance of alpha-ENaC was similar in
untreated and dDAVP-treated Brattleboro rats. dDAVP did
not increase the apical immunostaining for any ENaC
subunit.
The stimulatory effect of dDAVP on the intracellular
abundance of beta- and gamma-ENaC was apparent along
the entire collecting system, and appeared to increase from
the CNT towards the OMCDOS (collecting duct located in
the outer stripe of the outer medulla), as shown in Figure 3
for beta-ENaC.
To further confirm that dDAVP predominantly increased
the abundance of beta- and gamma-ENaC in the cytoplasm,
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Figure 1 | Immunohistochemical detection of AQP2, alpha-, beta-,
and gamma-ENaC subunits in representative CCD profiles of
Sprague–Dawley rats with different levels of vasopressin V2
receptor stimulation produced by chronic high water intake
(High water), no treatment (Control), or chronic dDAVP infusion
(dDAVP). Rats were kept on a standard sodium diet. Beta- and
gamma-ENaC subunits were found in the cytoplasm of the principal
cells. dDAVP induced a significant increase in the immunostaining
intensity of beta- and gamma-ENaC and in apical staining of AQP2.
Alpha-ENaC was barely detectable in any of these conditions.
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Figure 2 | Immunohistochemical detection of ENaC subunits in
representative CCD profiles of control and dDAVP-treated
homozygous Brattleboro rats. dDAVP markedly increased the
cytoplasmic staining of beta- and gamma-ENaC.
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Figure 3 | Distribution of beta-ENaC along the collecting system
of Sprague–Dawley rats with chronic HWI or dDAVP infusion. Rats
were kept on a standard sodium diet. CNT: connecting tubule, CCD:
cortical collecting duct, OMCDOS and OMCDIS: collecting duct located
in the outer stripe or inner stripe of the outer medulla, respectively.
The induction of the beta- (and gamma-, not shown) subunit is
heterogeneous along the distal nephron, with a gradient increasing
from the CNT to the OMCDOS.
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without any detectable increase in the insertion of ENaC into
the apical plasma membrane, we performed double-labelling
experiments with a biotin-conjugated membrane-binding
lectin and the ENaC antibodies. These preparations were
examined under high-resolution confocal microscopy.
Chronic dDAVP infusion profoundly increased the intra-
cellular pool of beta- and gamma-ENaC, but, in untreated as
well as in dDAVP-treated rats, the distinct lectin labelling of
the apical plasma membrane did not colocalize with labelling
of beta- and gamma-ENaC subunits, as shown in Figure 4 for
the beta-subunit.
Effect of vasopressin on ENaC localization in the kidneys of
rats with low Na intake
Dietary sodium restriction for 12 days enhanced the
immunohistochemical traceability of alpha-ENaC, and
shifted all three ENaC subunits towards the apical plasma
membrane (Figure 5), as reported previously.26,27 dDAVP
treatment did not further augment the apical immunostain-
ing for ENaC, but did increase the intracellular amounts of
both beta- and gamma-ENaC. HWI had no apparent effect
on ENaC immunostaining vs that in control rats.
Morphometry
To further validate the qualitative histological observations,
we used morphometric analysis to determine the percentage
of CNT, CCD, OMCDOS, and OMCDIS (collecting duct
located in the inner stripe of the outer medulla) exhibiting
apical ENaC subunit localization. In control rats on a
standard Na diet, tubular profiles with apical immunostain-
ing were found only for alpha-ENaC, and not for beta-
or gamma-ENaC. The apical alpha-ENaC localization was
most evident in the CNT and CCD (6275 and 4279% of
tubules displayed apical staining, respectively), was lower in
OMCDOS (873%), and was absent in OMCDIS (0%). Neither
HWI nor dDAVP treatment had any significant effect on the
percentage of tubular profiles with apical ENaC immuno-
staining (HWI: 5173, 3976, 672, and 070%; dDAVP:
4872, 3376, 372, and 070% in CNT, CCD, OMCDOS,
and OMCDIS, respectively). In contrast, dietary sodium
restriction profoundly increased the apical immunostaining
in CNT, CCD, OMCDOS, and the OMCDIS profiles for all
three ENaC subunits (analysis of variance (ANOVA),
Po0.0001). More than 85% of the CNT, CCD, and OMCDOS
profiles showed an apical alpha-ENaC immunostaining
(Figure 6). An apical localization for beta- and gamma-
ENaC was seen in more than 50% of the CNT and CCD
profiles. As for alpha-subunit in the kidney of rats on
standard diet, apical labelling of beta and gamma in kidney of
rats on low Na diet displayed a decreasing gradient from the
CCD to the medullary CDs (Po0.0001). HWI did not
significantly affect the percentage of tubules displaying apical
ENaC immunostaining. Surprisingly, dDAVP treatment
decreased the percentage of profiles with apical ENaC
staining. This decline reached statistical significance for beta-
and gamma-ENaC in almost all segments of the collecting
system, and for alpha-ENaC, only in OMCDIS.
Effect of vasopressin on the expression of ENaC regulatory
proteins
As reported previously,4 reverse transcriptase-polymerase
chain reaction results showed that sustained stimulation of
the vasopressin V2 receptor induced a significant increase in
mRNA levels of beta-ENaC subunit in the renal cortex
(Table 2). The mRNA expression of prostasin was signifi-
cantly enhanced by dDAVP infusion and was positively
correlated with that of beta-ENaC (y¼ 0.363xþ 0.665,
r¼ 0.550, P¼ 0.04). Vasopressin altered neither the abun-
dance of Sgk1 mRNA nor the abundance of Nedd4-2 mRNA
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Figure 4 | Confocal images of single CCD principal cells from
Sprague–Dawley rats on a standard sodium diet with HWI or
dDAVP infusion. Lycopersicon esculentum agglutinin (LEA)-related
red immunofluorescence is visible in the apical plasma membrane,
whereas beta-ENaC-related green immunofluorescence is seen in
intracellular compartments. dDAVP increased the cytoplasmic pool of
beta-ENaC, but did not increase its apical localization.
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Figure 5 | Influence of the level of V2 receptor activation on the
abundance and subcellular localization of ENaC subunits in CCD
of rats fed a low sodium diet. Apical labelling of the alpha-, beta-,
and gamma-subunits was visible under the three conditions of
urine-concentrating activity, but was not increased by dDAVP
treatment.
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(Table 2) and Nedd4 protein (1.0070.06 vs 0.9470.16 in
HWI and dDAVP group, respectively).
DISCUSSION
In this study, we investigated the long-term effect of
activating vasopressin V2 receptors on the distribution and
the subcellular localization of ENaC subunits along the distal
nephron, and the combined effect of vasopressin and low Na
intake/high aldosterone on the trafficking of the channel.
Moreover, we analyzed the effect of vasopressin on the
mRNA expression of proteins implicated in the regulation of
ENaC. Results reveal several new findings: (1) vasopressin
increased the abundance of the beta- and gamma-ENaC
subunits in the principal cells, with an axial gradient along
the renal collecting system; (2) this increase corresponded to
a greater intracellular pool of beta- and gamma-subunits with
no increase of any subunit at the cell surface; (3) vasopressin
did not further intensify the apical localization of ENaC
subunits induced by a low Na diet; and (4) vasopressin
increased slightly, although significantly, the mRNA expres-
sion of prostasin, a serine protease involved in the regulation
of ENaC activity.
Vasopressin has been previously reported to increase the
expression of beta- and gamma-ENaC subunits in whole rat
kidney, and the corresponding mRNAs in the cortex and
outer stripe of the outer medulla.3,4 Using immunohisto-
chemistry, we show clearly that vasopressin induced an
increase in the abundance of beta- and gamma-ENaC
subunits in the CNT cells and in the principal cells of the
CCD and OMCD. This induction was more pronounced in
the medullary portion than in cortical portion of the
collecting system, which probably corresponds to axial
differences in vasopressin V2 receptor sensitivity. Indeed,
the expression of vasopressin-dependent AQP2 is also higher
in OMCD than in CCD in rats deprived of water for 24 h.28
As reported previously,25 we found differing subcellular
localizations of the alpha-, beta- and gamma-subunits in the
principal cells, with alpha-ENaC present mainly at the apical
cell pole, whereas the beta- and gamma-subunits were
observed diffusely in the cytoplasm. We demonstrated that
an increase in the abundance of beta- and gamma-ENaC
induced by V2 agonist leads primarily to a greater
intracellular accumulation of these subunits. There was no
detectable increase of any subunit at the cell surface. This is
consistent with the fact that overexpression of ENaC subunits
in Xenopus oocytes does not increase the number of channels
in the plasma membrane.29 However, recent studies showed
that acute ENaC stimulation by cyclic AMP in renal cell lines
is the result of the trafficking of ENaC towards the apical
membrane from a recycling subapical channel pool.9,30 The
differences with our findings suggest a different ENaC
regulation in in vitro vs in vivo models. Moreover, the
response to acute vs chronic exposure to vasopressin might
be different. Our data do not exclude that vasopressin may
increase the apical localization of ENaC at earlier time points.
It is conceivable that an early ENaC activation and renal Na
retention by dDAVP may have activated compensatory
mechanisms that finally led to the retrieval of ENaC from
the cell surface and which thereby explains the predominant
intracellular localization of ENaC subunits seen in our study
after 5 days of chronic dDAVP exposure.
The present observation that a decrease in the endogenous
level of vasopressin induced by HWI does not induce any
significant change in immunohistochemical localization and
abundance in ENaC subunits is in agreement with the fact
that chronic administration of a selective V2 antagonist in
Sprague–Dawley rats did not alter ENaC mRNA abundance
(C Nicco and N Bouby, unpublished observations). This
suggests that the levels of vasopressin required to elicit an
effect on water transport are lower than those required to
elicit an effect on sodium transport, as proposed previously.31
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Figure 6 | Percentage of CNT, CCD, OMCDOS, and OMCDIS profiles
with apical labelling for alpha-, beta-, and gamma-ENaC in rats
on a low sodium diet, and with either HWI (open columns), no
treatment (shaded columns), or dDAVP infusion (black columns).
ANOVA followed by Fisher protected least significant difference post
hoc test, *Po0.05 dDAVP vs control, zPo0.05 dDAVP vs HWI.
Table 2 | Effect of chronic V2 receptor stimulation on the gene
expression of beta-ENaC and regulatory proteins in renal
cortex
Gene HWI n=7 dDAVP n=7
Beta-ENaC 1.0070.07 1.3170.09**
Prostasin 1.0070.06 1.1770.05*
Nedd4-2 1.0070.17 0.8970.10
Sgk1 1.0070.14 1.5570.43
dDAVP=1-deamino-8-D-arginine vasopressin (rats treated with vasopressin V2
agonist); HWI=high water intake.
Means7s.e.m. Values are expressed relative to the means of the HWI group.
Student’s t-test: *P=0.01, **P=0.05.
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In rat kidneys, aldosterone predominantly increases the
mRNA and protein abundance of alpha-ENaC,32–35 whereas
vasopressin induces predominantly the expression of beta-
and gamma-ENaC.3,4 This may finally lead to more channel
subunits available for complete assembly of channel com-
plexes and may allow an enhanced targeting of fully
assembled channels to the apical plasma membrane. A
potent stimulus for endogenous aldosterone production is
dietary sodium restriction. Like exogenous aldosterone
administration, dietary sodium restriction induces the
expression of alpha-ENaC and shifts all three ENaC subunits
from intracellular compartments towards the apical plasma
membrane.26,27 The apical translocation of ENaC in response
to dietary Na restriction is most pronounced in the early
CNT, and progressively diminishes along the CD from the
cortex to outer medulla27 (see Figure 6). Vasopressin induced
beta- and gamma-ENaC abundance predominantly in CDs.
Thus, it is possible to speculate that an enhanced induction of
beta- and gamma-ENaC by vasopressin could boost the
targeting of ENaC towards the apical plasma membrane
induced by dietary sodium restriction. Surprisingly, we
observed that sustained high levels of vasopressin did not
further increase the redistribution of ENaC subunits toward
the apical membrane, but even tended to reduce it. Our
findings therefore suggest that the abundance of gamma- and
beta-subunits is not per se the factor that limits the
overall capacity for increased apical channels in vivo.
Nevertheless, we cannot exclude that vasopressin may
increase the turnover of ENaC at the apical membrane as
our studies did only analyze the steady-state cell surface
expression of ENaC subunits. Moreover, the failure of
vasopressin to enhance the apical localization of the channel
in response to dietary sodium restriction could be due to the
low delivery of NaCl to the CCD under our experimental
conditions.36
Several mechanisms could be involved in the increase in
Na reabsorption induced by vasopressin in vivo. The non-
coordinate changes in individual subunit expression induced
by vasopressin could lead to a preferential assembly of ENaC
subunits in a stoechiometry different from that previously
proposed (2 alpha, 1 beta, 1 gamma).37 These channels may
have different biophysical properties (e.g. increased channel
conductance).38 Vasopressin could also have an indirect effect
on the structural domains of the protein that are essential for
channel function and/or for modulation of channel activity,
or have an effect on accessory proteins that might be involved
in the regulation of the channel activity.
The present study investigated for the first time the effect
of vasopressin on the gene expression of three proteins
known to regulate ENaC activity. Chronic dDAVP infusion
did not modify the plasma aldosterone concentration, and
thus, as expected,39 the expression of Sgk1 was unchanged.
Nedd4-2, an ubiquitin ligase, has been shown to be involved
in the internalization and degradation of the channel by
interacting with the intracellular C-domain of the subunits.40
The lack of effect of vasopressin on the mRNA expression of
Nedd4-2 and protein abundance of Nedd4 in renal cortex
suggests that the effect of vasopressin on ENaC involves
pathways other than an altered expression of Nedd4-2.
Remarkably, the mRNA expression of prostasin was found to
be increased by dDAVP in the present study. Although this
increase was rather modest, it was statistically significant and
positively correlated with the induction of beta-ENaC. This
extracellular membrane-anchored serine protease has been
shown to regulate ENaC activity in the epithelia of the kidney
and lung, in both mice and humans.41,42 Results obtained in
vitro have shown that serine proteases homologous to
prostasin increase the open probability of silent channels,43
and that the increase in amiloride short-circuit current is
accompanied by a reduction of channel molecules at the cell
surface.41 The upregulation of prostasin is in accord with the
absence of any increase in the apical localization of the
channel observed in the dDAVP-treated rats, and supports
the hypotheses that the V2 effect of vasopressin on ENaC-
mediated sodium transport in vivo could result from changes
in the apical turn over of the channel and/or activity of single
channels.
In conclusion, the present study shows that, in native renal
tissue, chronic activation of vasopressin V2 receptors
increases the cytoplasmic pool of the beta- and gamma-
subunits of ENaC, but does not increase the apical
localization of ENaC. This suggests that in vivo chronic
elevation of vasopressin plasma level may stimulate Na
transport through ENaC in some other way than by
enhancing the abundance of the channel to the membrane.
MATERIALS AND METHODS
Animals and treatments
All animal procedures were conducted in accordance with European
guidelines for the care and use of laboratory animals. Thirty male
Sprague–Dawley rats (Harlan, Horst, The Netherlands), with body
weight of approximately 200 g, were fed for 12 days with either a
standard (std. Na: 0.26%) or a low (low Na: 0.01%) sodium diet and
were subjected during the last 5 days to one of the three protocols
inducing various levels of activation of vasopressin V2 receptors
(N¼ 5 per group). One-third of the rats was treated with the V2
agonist, dDAVP (Minirin, Ferring Malmo, Sweden), infused
continuously through osmotic minipumps (Alzet, models 2002,
Palo Alto, CA, USA) (200 ng/day) implanted subcutaneously. The
second third received a diet with high water content (HWI) by
mixing the food with a water-rich agar gel (40 mg agar and 4 ml
water/g food).44 The last third was used as control (CONT). To
achieve the same intake in all groups, 15 g dry food/day was given to
all rats, a value slightly lower than their spontaneous intake. All the
rats had free access to tap water.
Additional groups of Sprague–Dawley rats (Iffa Credo, L’Ar-
bresle, France) were used for the molecular study. They were fed
standard Na diet and treated for 5–10 days either with dDAVP or
HWI (n¼ 7 per group) as described above.
In another set of experiments, male homozygous Brattleboro rats
(Harlan, Indianapolis, IN, USA), with hereditary diabetes insipi-
dus,23 fed a standard sodium diet were infused for 5 days with
dDAVP as described above for Sprague–Dawley rats, and compared
to untreated Brattleboro rats (n¼ 5 per group).
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Measurement of functional data
The rats were housed individually in metabolic cages during the last
3 days of the study. Body weight, water intake, and urinary flow rate
were measured during the last 2 days. At the end of the experiments,
blood samples were taken from the inferior vena cava under
anaesthesia. The following parameters were measured in the plasma
and urine samples: osmolality (freezing point osmometer, Roebling,
Berlin, Germany), sodium and potassium concentrations (flame
photometer, Instrumentation Laboratory, model 943, Paris, France),
and urea concentration (Urea Kit, BioMe´rieux, Lyon, France).
Plasma aldosterone was measured by radioimmunoassay (Cis Bio
International, Gif/Yvette, France).
Immunohistochemistry
The kidneys were fixed by retrograde perfusion through the
abdominal aorta. The fixative consisted of 3% paraformaldehyde
and 0.05% picric acid dissolved in a 3:2 mixture of 0.1 M cacodylate
buffer (pH 7.4, adjusted to 300 mOsm with sucrose) and 10%
hydroxyethyl starch in saline (HAES-sterile; Fresenius, Stans,
Switzerland). After 5 min, the fixative was washed out by 5 min
perfusion of cacodylate buffer. The kidneys were then removed, cut
into coronal slices, mounted on small cork disks, and rapidly frozen
in liquid propane. Serial sections (4mm thick) were cut in a cryostat,
placed on chrom-alum gelatin-coated glass slides, thawed, and
immediately processed for immunohistochemistry. After preincuba-
tion for 10 min with 10% normal goat serum in phosphate-buffered
saline (PBS), the sections were incubated with a 1/500 dilution of
rabbit-anti-rat AQP2 immunoglobulin G (Alamone labs, Jerusalem,
Israel), a 1/500 dilution of rabbit-anti-rat alpha-ENaC antiserum,22
a 1/1000 dilution of rabbit-anti-rat beta-ENaC antiserum,22 or a
1/400 dilution of rabbit-anti-rat gamma-ENaC antiserum.22 Mono-
clonal mouse-anti-chicken calbindin D28k antibody (SWANT,
Bellinzona, Switzerland), diluted 1/20 000, was applied together
with the rabbit polyclonal antibodies. Incubations with the primary
antibodies, diluted in PBS/bovine serum albumin 1%, were
performed overnight in a humidified chamber at 41C. After
repeated washes with PBS, the binding sites of the primary
antibodies were revealed with a Cy3-conjugated donkey-anti-rabbit
immunoglobulin G (Jackson Immuno Research Laboratories, West
Grove, PA, USA) and with fluorescein isothiocyanate-conjugated
goat-anti-mouse immunoglobulin G (Jackson Immuno Research
Laboratories), diluted 1/1000 and 1/40 in PBS/bovine serum
albumin 1%, respectively. Sections were then washed with
PBS and coverslips were mounted using DAKO-glycergel
(Dakopatts, Denmark) to which the fading retardant 2.5% 1,
4-diazabicyclo(2,2,2)octane (Sigma, St Louis, MO, USA) was
added. For control of the nonspecific antibody binding, the
primary antibodies were omitted or replaced by non-immune
rabbit sera. Sections were studied by epifluorescence using a
Polyvar microscope (Reichert-Jung, Vienna, Austria). Digital
images were acquired with a VISICAM charged-coupled
device camera (Visitron, Puchheim, Germany) and processed by
Image-Pro Plus v.3.0 software (Media Cybernetics, Silver Spring,
MD, USA).
For confocal microscopy, immunostaining for ENaC subunits
was combined with labelling of the apical plasma membrane with a
1/500 dilution of biotin-conjugated Lycopersicon esculentum agglu-
tinin (Sigma), followed by a 1/100 dilution of fluorescein
isothiocyanate-conjugated streptavidin (Bioscience Products, Em-
menbruecke, Switzerland). The stained cryosections were studied
with a confocal laser-scanning microscope (model TLS SP; Leica,
Heidelberg, Germany) using the 488 and 568 nm laser lines of an
argon/krypton laser to excite fluorescein isothiocyanate and Cy3,
respectively. Images of fluorescein isothiocyanate- and Cy3-related
fluorescence were acquired sequentially to exclude interference
between the two channels.
Identification of tubular segments
The segments of the renal collecting system were identified
according to morphological and immunohistochemical criteria.
The CNT, located in the cortical labyrinth, is characterized by co-
expressing ENaC and calbindin D28k, whereas the CCD is located in
the medullary rays and does not express any or very low levels of
calbindin D28k.45 The outer medullary CD was identified as ENaC-
positive tubular profiles located in the outer (OMCDOS) or inner
stripe (OMCDIS) of the outer medulla.
Morphometric measurements
At least four coronal kidney sections, each taken from
different tissue slices, were analyzed for each rat. The sections,
comprising the cortex and the outer and inner medulla,
were examined using a  40 objective. CNT, CCD, OMCDOS,
and OMCDIS profiles with apical immunostaining for ENaC
subunits were counted and expressed as percentage of the
total number of CNT, CCD, OMCDOS, and OMCDIS profiles
identified in each section. Using this procedure, more than 100
profiles for each ENaC subunit, in each segment, of each rat were
analyzed.
Real-time quantitative reverse transcriptase-polymerase
chain reaction
The total RNA was extracted from 100 mg of renal cortex using the
RNA Plus kit (Qbioge`ne, Illkirch, France). The quality of isolated
RNA was checked by gel electrophoresis in denaturing conditions
and total RNA concentration was determined by measurement of
optical density at 260 nm. Total RNA (1 mg) were reverse transcribed
using random hexamers and Superscript II reverse transcriptase
(Invitrogen, Cergy Pontoise, France). Reverse transcriptase-negative
controls were performed to assess the presence of possible genomic
contamination. Real-time polymerase chain reaction reactions were
performed on an ABI Prism 7000 sequence detection system
(Applied Biosystems, Foster City, CA, USA) by using 2.5 ml of the
40-ml reverse transcriptase reaction product and the TaqMan
Universal PCR Master Mix (Applied Biosystems) and Assays-on-
Demand Expression probes (Applied Biosystems) for beta-ENaC,
prostasin, Sgk1, and 18S ribosomal RNA. Oligonucleotide primers
and Taqman probe for Nedd4-2 were designed on exon 12
(XM_214557) with the Primer Express 2.0 software program
(forward: 50-CATGTTACTGATGGACATTATCGT TCA-30; reverse:
50-TGAACACCCGTGACAGTTGAC-30; probe: 50-FAM-GCACCC
CAA CTAGGCGAGCCCGT-TAMRA-30) and manufactured by
Proligo (Paris, France). The thermal cycling conditions comprised
an initial denaturing step at 951C for 10 min, followed by 40 cycles at
951C for 15 s and 601C for 1 min. All reactions were run in triplicate
and included negative control. Relative quantitation of gene
expression was determined using the comparative Ct method with
validation experiments performed to determine that amplification
efficiencies were close to 98–100%. Results were normalised with the
data obtained from the 18S ribosomal RNA endogenous control
and expressed relative to the mean of the HWI group that was
defined as 1.00.
1030 Kidney International (2006) 69, 1024–1032
o r i g i n a l a r t i c l e D Sauter et al.: ENaC subcellular localization and vasopressin
Western analysis
Nedd4 protein expression was analyzed by Western blotting.
Homogenates were prepared from renal cortex (excised under a
dissecting microscope), lung, and colon as follows. Tissues were
placed into ice-cold isolation buffer (250 mM sucrose, 20 mM Tris-
HEPES, pH 7.4) containing protease inhibitors: 4 mg/ml aprotinin,
4 mg/ml leupeptin, 1.5 mg/ml pepstatin A, and 28 mg/ml 4-(2-
aminoethyl)-benzenesulphonyl fluoride. Minced tissues were homo-
genized in a Dounce homogeniser (pestle A 5), followed by five
passes through a Teflon-glass homogeniser rotating at 1000 r.p.m.
The homogenate was centrifuged at 1000 g for 10 min at 41C.
Proteins were solubilized in loading buffer, incubated at 201C for
30 min. Proteins were then separated by 7.5% sodium dodecyl
sulphate-polyacrylamide gel electrophoresis and transferred to
Hybond ECL nitrocellulose (Amersham Pharmacia Biotech, Saclay,
France) and analyzed by Western blotting. Nitrocellulose mem-
branes were first incubated in 5% non-fat dry milk in PBS, pH 7.4,
for 1 h at room temperature to block nonspecific binding of
antibody, followed by overnight at 41C with anti-Nedd4 WW2
domain (Upstate Biotechnology, VA, USA) antibody diluted
1:20 000 in PBS containing 1% non-fat dry milk. After four 5-min
washes in PBS containing 0.1% Tween-20, membranes were
incubated with 1:3000 dilution of goat anti-rabbit immunoglobulin
G conjugated to horseradish peroxidase (Bio-Rad, Hercules, CA,
USA) in PBS containing 5% non-fat dry milk for 2 h at room
temperature. Blots were washed as above, and luminol-enhanced
chemiluminescence (NEN Life Science Products, Courtaboeuf,
France) was used to visualize bound antibodies on Polaroid film.
The autoradiographs were digitised by laser scanner (Epson
Perfection 1650; Epson), and bands were quantified using NIH
Image software. Densitometric values were normalized to the mean
for the HWI group that was defined as 100%.
Statistical analysis
Results are expressed as the mean7s.e.m. of n rats. For the functional
and morphological studies, the statistical significance of the differences
observed among the groups was assessed by multiway ANOVA with
sodium diet (normal or low), treatment (control, dDAVP, or high
water), and segment of tubules as test factors. The ANOVA tests were
followed, when appropriate, by the Fisher protected least significant
difference post hoc test. The statistical significance of the differences
observed between the two groups of Brattleboro rats were assessed by
Student’s t-test. Data from the molecular study were analyzed using
the Student’s t-test. StatView F-5.0 software was used for the statistical
analysis. The chosen level of significance was Pp0.05.
ACKNOWLEDGMENTS
The study was supported by the Nestle Water Institute (Dr MJ
Arnaud) (to NB), the Swiss National Science Foundation Grant
32-061742.00, and the EMDO Foundation (to JL). We would like to
thank Catherine Chollet (INSERM U652, Paris, France) for her technical
assistance, Annette Hus-Citharel (INSERM U691, Paris, France), Brigitte
Kaissling (Institute of Anatomy, Zu¨rich, Switzerland), Bernard Rossier
and Edith Hummler (Institute of Pharmacology and Toxicology,
Lausanne, Switzerland), and Franc¸ois Alhenc-Gelas (INSERM U652,
France) for critical reading of the manuscript and Nicolette Farman
(INSERM U478, Paris, France) for fruitful discussion.
REFERENCES
1. Canessa CM, Schild L, Buell G et al. Amiloride-sensitive epithelial Na+
channel is made of three homologous subunits. Nature 1994; 367:
463–467.
2. Djelidi S, Fay M, Cluzeaud F et al. Transcriptional regulation of sodium
transport by vasopressin in renal cells. J Biol Chem 1997; 272:
32919–32924.
3. Ecelbarger CA, Kim GH, Terris J et al. Vasopressin-mediated regulation of
epithelial sodium channel abundance in rat kidney. Am J Physiol – Renal
Physiol 2000; 279: F46–F53.
4. Nicco C, Wittner M, DiStefano A et al. Chronic exposure to vasopressin
upregulates ENaC and sodium transport in the rat renal collecting duct
and lung. Hypertension 2001; 38: 1143–1149.
5. Marunaka Y, Eaton DC. Effects of vasopressin and cAMP on single
amiloride-blockable Na channels. Am J Physiol 1991; 260: C1071–C1084.
6. Kleyman TR, Ernst SA, Coupaye-Gerard B. Arginine vasopressin and
forskolin regulate apical cell surface expression of epithelial Na+ channels
in A6 cells. Am J Physiol 1994; 266: F506–F511.
7. Verrey F, Groscurth P, Bolliger U. Cytoskeletal disruption in A6 kidney
cells: impact on endo/exocytosis and NaCl transport regulation by
antidiuretic hormone. J Membr Biol 1995; 145: 193–204.
8. Butterworth MB, Helman SI, Els WJ. cAMP-sensitive endocytic trafficking
in A6 epithelia. Am J Physiol Cell Physiol 2001; 280: C752–C762.
9. Morris RG, Schafer JA. cAMP increases density of ENaC subunits in the
apical membrane of MDCK cells in direct proportion to amiloride-
sensitive Na(+) transport. J Gen Physiol 2002; 120: 71–85.
10. Nielsen S, Frokiaer J, Marples D et al. Aquaporins in the kidney: from
molecules to medicine. Physiol Rev 2002; 82: 205–244.
11. Schafer JA. Abnormal regulation of ENaC: syndromes of salt retention and
salt wasting by the collecting duct. Am J Physiol Renal Physiol 2002; 283:
F221–F235.
12. Vallon V, Lang F. New insights into the role of serum- and
glucocorticoid-inducible kinase SGK1 in the regulation of renal function
and blood pressure. Curr Opin Nephrol Hypertens 2005; 14: 59–66.
13. Reif M, Troutman SL, Schafer JA. Sodium transport by rat cortical
collecting tubule. Effects of vasopressin and desoxycorticosterone. J Clin
Invest 1986; 77: 1291–1298.
14. Verrey F. Antidiuretic hormone action in A6 cells: effect on apical Cl and
Na conductances and synergism with aldosterone for NaCl reabsorption.
J Membr Biol 1994; 138: 65–76.
15. Hawk CT, Li L, Schafer JA. AVP and aldosterone at physiological
concentrations have synergistic effects on Na+ transport in rat CCD.
Kidney Int 1996; 57: S35–S41.
16. Alfaidy N, Blot-Chabaud M, Bonvalet JP, Farman N. Vasopressin
potentiates mineralocorticoid selectivity by stimulating 11 beta
hydroxysteroid deshydrogenase in rat collecting duct. J Clin Invest 1997;
100: 2437–2442.
17. Snyder PM, Olson DR, Kabra R et al. cAMP and serum and
glucocorticoid-inducible kinase (SGK) regulate the epithelial Na(+)
channel through convergent phosphorylation of Nedd4-2. J Biol Chem
2004; 279: 45753–45758.
18. Awayda MS, Tousson A, Benos DJ. Regulation of a cloned epithelial Na+
channel by its beta- and gamma-subunits. Am J Physiol 1997; 273:
C1889–C1899.
19. Snyder PM. Liddle’s syndrome mutations disrupt cAMP-mediated
translocation of the epithelial Na(+) channel to the cell surface. J Clin
Invest 2000; 105: 45–53.
20. Bonny O, Chraibi A, Loffing J et al. Functional expression of a
pseudohypoaldosteronism type I mutated epithelial Na+ channel lacking
the pore-forming region of its alpha subunit. J Clin Invest 1999; 104:
967–974.
21. May A, Puoti A, Gaeggeler HP et al. Early effect of aldosterone on the rate
of synthesis of the epithelial sodium channel alpha subunit in A6 renal
cells. J Am Soc Nephrol 1997; 8: 1813–1822.
22. Rubera I, Loffing J, Palmer LG et al. Collecting duct-specific gene
inactivation of alphaENaC in the mouse kidney does not impair sodium
and potassium balance. J Clin Invest 2003; 112: 554–565.
23. Valtin H. Genetic models of diabetes insipidus. In: Windhager E (ed).
Handbook of Physiology, vol. 2, Oxford University Press: New York, 1992
pp 1281–1315.
24. Fernandes S, Bruneval P, Hagege A et al. Chronic V2-vasopressin
receptor stimulation increases basal blood pressure and exacerbates
desoxycorticosterone acetate-salt hypertension. Endocrinology 2002;
143: 2759–2766.
25. Hager H, Kwon TH, Vinnikova AK et al. Immunocytochemical and
immunoelectron microscopic localization of alpha-, beta-, and gamma-
ENaC in rat kidney. Am J Physiol Renal Physiol 2001; 280: F1093–F1106.
26. Masilamani S, Kim GH, Mitchell C et al. Aldosterone-mediated regulation
of ENaC a, b and g subunit proteins in rat kidney. J Clin Invest 1999; 104:
R19–R23.
Kidney International (2006) 69, 1024–1032 1031
D Sauter et al.: ENaC subcellular localization and vasopressin o r i g i n a l a r t i c l e
27. Loffing J, Pietri L, Aregger F et al. Differential subcellular localization of
ENaC subunits in mouse kidney in response to high- and low-Na diets.
Am J Physiol Renal Physiol 2000; 279: F252–F258.
28. Kishore BK, Terris TM, Knepper MA. Quantitation of aquaporin-2
abundance in microdissected collecting ducts: axial distribution and
control by AVP. Am J Physiol 1996; 271(Part 2): F62–F70.
29. Valentijn JA, Fyfe GK, Canessa CM. Biosynthesis and processing of
epithelial sodium channels in Xenopus oocytes. J Biol Chem 1998; 273:
30344–30351.
30. Butterworth MB, Edinger RS, Johnson JP, Frizzell RA. Acute ENaC
stimulation by cAMP in a kidney cell line is mediated by exocytic
insertion from a recycling channel pool. J Gen Physiol 2005; 125:
81–101.
31. Bankir L. Antidiuretic action of vasopressin: quantitative aspects and
interaction between V1a and V2 receptor-mediated effects. Cardiovasc
Res 2001; 51: 372–390.
32. Renard S, Voilley N, Bassilana F et al. Localization and regulation by
steroids of the a, b, and g subunits of the amiloride-sensitive Na+ channel
in colon, lung and kidney. Pflu¨gers Arch 1995; 430: 299–307.
33. Escoubet B, Coureau C, Bonvalet JP et al. Noncoordinate regulation of
epithelial Na channel and Na pump subunit mRNAs in kidney and colon
by aldosterone. Am J Physiol 1997; 272: C1482–C1491.
34. Stokes JB, Sigmund RD. Regulation of rENaC mRNA by dietary NaCl and
steroids: organ, tissue, and steroid heterogeneity. Am J Physiol 1998; 274:
C1699–C1707.
35. MacDonald P, MacKenzie S, Ramage LE et al. Corticosteroid regulation of
amiloride-sensitive sodium-channel subunit mRNA expression in mouse
kidney. J Endocrinol 2000; 165: 25–37.
36. Schafer JA, Chen L. Low Na+ diet inhibits Na+ and water transport response
to vasopressin in rat cortical collecting duct. Kidney Int 1998; 54: 180–187.
37. Firsov D, Gautschi I, Merillat AM et al. The heterotetrameric architecture
of the epithelial sodium channel (ENaC). EMBO J 1998; 17: 344–352.
38. Weisz OA, Johnson JP. Noncoordinate regulation of ENaC: paradigm lost?
Am J Physiol Renal Physiol 2003; 285: F833–F842.
39. Loffing J, Zecevic M, Feraille E et al. Aldosterone induces rapid apical
translocation of ENaC in early portion of renal collecting system: possible
role of SGK. Am J Physiol Renal Physiol 2001; 280: F675–F682.
40. Staub O, Dho S, Henry P et al. WW domains of Nedd4 bind to the
proline-rich PY motifs in the epithelial Na+ channel deleted in Liddle’s
syndrome. EMBO J 1996; 15: 2371–2380.
41. Vuagniaux G, Vallet V, Jaeger NF et al. Activation of the amiloride-
sensitive epithelial sodium channel by the serine protease mCAP1
expressed in a mouse cortical collecting duct cell line. J Am Soc Nephrol
2000; 11: 828–834.
42. Donaldson SH, Hirsh A, Li DC et al. Regulation of the epithelial sodium
channel by serine proteases in human airways. J Biol Chem 2002; 277:
8338–8345.
43. Caldwell RA, Boucher RC, Stutts MJ. Serine protease activation of
near-silent epithelial Na+-channels (ENaC). Am J Physiol Cell Physiol 2004;
286: C190–C194.
44. Bouby N, Bachmann S, Bichet D, Bankir L. Effect of water intake on the
progression of chronic renal failure in the 5/6 nephrectomized rat. Am J
Physiol (Renal Fluid Electrolyte Physiol; 27) 1990; 258: F973–F979.
45. Taylor AN, McIntosh JE, Bourdeau JE. Immunocytochemical localization of
vitamin D-dependent calcium-binding protein in renal tubules of rabbit,
rat, and chick. Kidney Int 1982; 21: 765–773.
1032 Kidney International (2006) 69, 1024–1032
o r i g i n a l a r t i c l e D Sauter et al.: ENaC subcellular localization and vasopressin
